Similar articles

• Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.

  Bentin J, Carson DA, Vaughan JH, Tsoukas CD. Bentin J, et al. Transplantation. 1986 Sep;42(3):317-20. Transplantation. 1986. PMID: 3092413 No abstract available.
• Monoclonal antibodies to CD2 and lymphocyte function-associated antigen 3 inhibit human thymic epithelial cell-dependent mature thymocyte activation.

  Denning SM, Tuck DT, Vollger LW, Springer TA, Singer KH, Haynes BF. Denning SM, et al. J Immunol. 1987 Oct 15;139(8):2573-8. J Immunol. 1987. PMID: 3116085
• Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.

  Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS. Chavin KD, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):823-4. Transplant Proc. 1993. PMID: 8094913 No abstract available.
• Activation of T lymphocytes via monoclonal antibodies against rat cell surface antigens with particular reference to CD2 antigen.

  Beyers AD, Barclay AN, Law DA, He Q, Williams AF. Beyers AD, et al. Immunol Rev. 1989 Oct;111:59-77. doi: 10.1111/j.1600-065x.1989.tb00542.x. Immunol Rev. 1989. PMID: 2576418 Review.
• Recent studies in lymphocyte activation.

  Wedner HJ. Wedner HJ. Year Immunol. 1986;2:145-51. Year Immunol. 1986. PMID: 2437725 Review. No abstract available.